Insomnia as a Psychiatric Symptom: When Sleep Problems Need More Than Sleep Hygiene
Insomnia is one of the most common complaints in psychiatric practice — and one of the most undertreated. Sleep hygiene advice is useful but insufficient when insomnia is driven by a psychiatric condition.
Quick answer
Insomnia driven by anxiety, depression, PTSD, or other psychiatric conditions will not resolve with sleep hygiene alone. These conditions directly disrupt the neurological processes that produce sleep. Treating the underlying psychiatric condition alongside CBT-I is the most effective approach.
When Insomnia Is a Psychiatric Symptom
Insomnia is listed as a diagnostic criterion for major depressive disorder, generalized anxiety disorder, PTSD, and bipolar disorder. The relationship between insomnia and psychiatric conditions is bidirectional and mutually reinforcing. Depression disrupts sleep architecture and causes insomnia; insomnia worsens depression by impairing neurological processes that regulate mood. Anxiety activates the sympathetic nervous system at bedtime when sleep requires a parasympathetic shift; difficulty sleeping then increases anxiety about sleep, producing conditioned arousal.
The clinical signal that insomnia requires psychiatric evaluation includes: duration more than three months; accompanying mood disturbance, anxiety, or trauma history; non-response to sleep hygiene and behavioral interventions; significant functional impairment; and insomnia in the context of medications or substances affecting sleep architecture.
In East Texas, where primary care access is stretched, patients with psychiatric insomnia often receive sleep hygiene education and a Z-drug (zolpidem, eszopiclone) without evaluation of the underlying psychiatric driver. This provides short-term relief without addressing the mechanism, and Z-drug dependence develops more readily in people whose insomnia is driven by untreated psychiatric conditions.
Why Sleep Hygiene Is Not Enough
Sleep hygiene addresses behaviors; psychiatric insomnia is driven by neurobiological mechanisms. A consistent sleep schedule does not reverse the sleep architecture disruption of major depression, which involves reduced slow-wave sleep and abnormal REM timing driven by monoaminergic dysfunction, elevated cortisol, and inflammatory cytokines — not by irregular bedtimes. Keeping the room dark does not reduce amygdala hyperreactivity that anxiety brings to bedtime.
Conditioned arousal develops readily in chronic insomnia: the bed and bedroom become associated with wakefulness and distress. This conditioned association does not resolve with sleep hygiene; it requires CBT-I techniques — specifically sleep restriction and stimulus control — that extinguish the conditioned wakefulness response.
Cognitive factors maintain insomnia independently of the original cause. Maladaptive beliefs about sleep — “I cannot function on less than eight hours” — increase arousal and performance anxiety, maintaining insomnia even when the psychiatric driver is partially addressed. These require cognitive restructuring through CBT-I.
What Actually Works
CBT-I (Cognitive Behavioral Therapy for Insomnia) is the gold-standard treatment for chronic insomnia and outperforms sleep medication in long-term outcomes across multiple randomized controlled trials. Its core components: sleep restriction (initially limiting time in bed to actual sleep time, consolidating sleep and building sleep pressure); stimulus control (using the bed only for sleep and sex, getting out of bed after 20 minutes of wakefulness to re-associate the bed with sleep); cognitive restructuring of maladaptive sleep beliefs; sleep hygiene optimization; and relaxation training. CBT-I is available through sleep-trained therapists and validated digital programs including Sleepio and Somryst.
Treating the underlying psychiatric condition is parallel and essential. SSRIs and SNRIs address the anxiety and depression driving the insomnia. Prazosin specifically reduces PTSD nightmares and is a valuable addition for PTSD-related sleep disruption. Effective psychiatric treatment normalizes sleep architecture alongside mood — the sleep problem often improves significantly as the psychiatric condition responds, particularly when the antidepressant chosen does not have activating properties that disrupt sleep.
Non-addictive pharmacological support is appropriate short-term while psychiatric treatment and CBT-I take effect. Preferred options include: trazodone (25–100 mg at bedtime, commonly added to SSRIs to counteract activating effects while providing sedation); mirtazapine at low doses (sedating, useful when weight gain is acceptable); low-dose quetiapine (used off-label for PTSD-related hyperarousal insomnia); and hydroxyzine (antihistamine with anxiolytic and sedating properties). Z-drugs and benzodiazepines carry dependency and tolerance risk and are not preferred for chronic psychiatric insomnia.
Timing and sequencing. For patients whose antidepressant is causing sleep disruption (a common early side effect of activating SSRIs and SNRIs), taking the medication in the morning rather than at night and adding a short-term sleep-supportive agent bridges the adjustment period until sleep side effects resolve, typically within the first two to four weeks.
ETX Psychiatry evaluates and treats psychiatric insomnia as part of comprehensive mental health care. We provide referrals to CBT-I trained therapists and identify digital CBT-I programs. Call (430) 288-5800 or schedule online. We accept Medicare, Aetna, BCBS, Cigna, Optum, UHC, UMR, and Ambetter. 100 Independence Pl, Suite 405, Tyler, TX 75703. Telehealth available.
Getting Help for Insomnia in East Texas
At ETX Psychiatry, sleep is assessed at every psychiatric evaluation and included in ongoing medication management as a specific treatment target rather than a secondary complaint. Medication selection accounts for sleep: choosing antidepressants that support rather than disrupt sleep, timing medications to minimize activating effects at bedtime, and adding sleep-supportive agents when needed during the treatment period.
We provide referrals to CBT-I trained therapists in the East Texas region and can identify digital CBT-I programs for patients where in-person access to a sleep therapist is limited. Our goal is durable insomnia improvement — not indefinite medication dependence on Z-drugs or benzodiazepines that address the symptom while the underlying condition continues untreated.
For patients in East Texas who have been managing insomnia with zolpidem prescribed by a primary care provider without adequate evaluation of the underlying psychiatric driver, a psychiatric evaluation provides a more comprehensive approach. Many of these patients have unrecognized anxiety disorder, PTSD, or depression that is fully treatable and whose treatment would produce sustained improvement in sleep without ongoing sedative-hypnotic use.
ETX Psychiatry serves Tyler, Longview, Lufkin, Nacogdoches, and East Texas patients via telehealth. To schedule, call (430) 288-5800.
Key Takeaways
- Insomnia in depression, anxiety, and PTSD is driven by neurobiological mechanisms that sleep hygiene cannot address
- Conditioned arousal — the bed becoming associated with wakefulness — requires CBT-I to extinguish
- CBT-I outperforms sleep medication in long-term outcomes and is the gold-standard treatment for chronic insomnia
- Treating the underlying psychiatric condition is parallel and essential — the insomnia will persist if the driver is not addressed
- Non-addictive sleep support (trazodone, mirtazapine, quetiapine, hydroxyzine) is preferred over Z-drugs for psychiatric insomnia
Frequently Asked Questions
Why does my doctor keep prescribing zolpidem instead of treating my anxiety?
Z-drugs provide rapid symptom relief and require less clinical time than addressing underlying anxiety. For chronic psychiatric insomnia, they are not the optimal long-term approach. A psychiatric evaluation can address both the anxiety and the insomnia more comprehensively.
Can I do CBT-I at home?
Yes. Validated digital CBT-I programs (Sleepio, Somryst) have clinical trial evidence supporting their effectiveness. They are less individually tailored than working with a sleep therapist but are accessible without a separate appointment and are appropriate for many patients.
Does treating my depression actually improve my sleep?
Yes. Effective antidepressant treatment improves sleep architecture, reducing the REM abnormalities and slow-wave sleep suppression of depression. Sleep improvement often tracks mood improvement. Activating antidepressants may initially disrupt sleep — timing adjustments or adding a sleep-supportive agent typically addresses this.
Is it safe to take trazodone long-term for sleep?
Trazodone has a low side effect burden, does not produce tolerance or physical dependence, and is considered safe for long-term use. It is among the most commonly used non-addictive sleep aids in psychiatric practice.
What is the difference between insomnia disorder and poor sleep hygiene?
Insomnia disorder is a clinical condition involving persistent difficulty initiating or maintaining sleep despite adequate opportunity, causing functional impairment, for at least three months. Poor sleep hygiene is a behavioral pattern. Insomnia disorder often involves conditioned arousal and cognitive factors that persist even when hygiene improves.
Does PTSD cause insomnia?
Yes. PTSD produces nightmares, hypervigilance that prevents sleep onset, and sleep fragmentation that significantly reduces sleep quality. PTSD-related insomnia requires treating the PTSD (medication plus PE, CPT, or EMDR) alongside specific sleep interventions including prazosin for nightmares.
When should I seek psychiatric evaluation for insomnia?
When insomnia has lasted more than three months, accompanies mood or anxiety symptoms, has not responded to sleep hygiene and basic behavioral changes, or is producing significant functional impairment. You do not need to exhaust all self-help options before seeking evaluation.
Is melatonin helpful for psychiatric insomnia?
Melatonin has a modest evidence base for circadian rhythm disorders and jet lag but limited evidence for psychiatric insomnia specifically. It is not sedating in the way that trazodone or mirtazapine are, and it does not address the conditioned arousal or the underlying psychiatric condition driving the insomnia. It is safe and may be worth trying as an adjunct for sleep onset difficulty, but it is not a substitute for treating the underlying condition or for CBT-I.
